Alcon selects Varicent for sales performance management solutions Varicent Software Incorporated, the leading innovator in incentive compensation and sales performance management solutions, announced today that it will provide its innovative solutions to Alcon, the world’s largest eye-care company. With thousands of salespeople, working in 75 countries, Alcon wanted a thorough and scalable solution to handle the complexity and magnitude of its organization. After a thorough evaluation of the many options available on the market, we decided Varicent was the very best product to control Alcon’s sales performance management needs, stated Matt von Wellsheim, Alcon’s CIO and Vice President of Information Technologies http://www.prednisolone.org/category/health .
Licensed from medwireNews with permission from Springer Healthcare Ltd. All privileges reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.. Alectinib promise for crizotinib-resistant NSCLC By Lucy Piper, Senior medwireNews Reporter Alectinib shows promising antitumour activity in patients with ALK-rearranged non-small-cell lung cancer tumor that’s resistant to crizotinib, researchers report. In the current dose-finding area of the AF-002JG study, 47 sufferers with ALK-rearranged NSCLC started oral alectinib twice a day a median of 18 days after discontinuing crizotinib. The dose varied from 300 to 900 mg.